Medley Pharmaceuticals Limited, a active public limited company, was established on 15 April 1975 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1975PLC018296. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹33.00 Cr and a paid-up capital of ₹30.06 Cr.
Formerly known as Medley Pharmaceuticals Private Limited. It upholds a compliant status. Employing 2,852 professional, Its leadership includes Sahir Sami Khatib (Whole-Time Director), Mohamed Aslam Abdul Rahman Sheikh (Director), Saba Mir Asif Ali (Whole-Time Director). Past directors included Firdaus Jehangir Tarachand, Mayank Bhargava, Vimalkumar Shyam Varma. It holds ₹57.40 Cr open charges and ₹254.55 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Medley Housed 2 M I D C Area Andheri (East), Mumbai, Maharashtra, 400093.
U24230MH1975PLC018296
018296
15 April 1975
₹33.00 Cr
₹30.06 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medley Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sahir Sami Khatib | Whole-Time Director | 01 Apr 2015 | Current |
| Mohamed Aslam Abdul Rahman Sheikh | Director | 28 Jun 2024 | Current |
| Saba Mir Asif Ali | Whole-Time Director | 24 Feb 2015 | Current |
| Suhel Sami Khatib | Director | 01 Apr 2010 | Current |
| Sarosh Sami Khatib | Managing Director | 17 Jul 1987 | Current |
| Sucheta Mudgerikar | Director | 25 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo(Kmp) | 30 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | 14 Aug 2009 | Past |
| Pramod Abcsdd | Director | 21 Apr 2012 | Past |
| Pramod Abcsdd | Ceo | - | Past |
| Pramod Abcsdd | Director | 13 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medley Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 10.68% increase. The company also saw a substantial improvement in profitability, with a 22.34% increase in profit. The company's net worth Soared by an impressive increase of 13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Medley Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹574,000,000.00
₹2,545,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2025 | Others | ₹20.00 Cr | Open |
| 17 Jun 2022 | Others | ₹20.00 Cr | Open |
| 15 Apr 2021 | Others | ₹1.00 M | Open |
| 31 Mar 1999 | State Bank Of India | ₹17.30 Cr | Open |
| 30 Mar 2015 | Icici Bank Limited | ₹6.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Medley Pharmaceuticals has a workforce of 2852 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medley Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medley Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101198123 was registered on 02 Dec 2025. was documented.
Progress on Medley Pharmaceuticals Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was documented.
The activity Medley Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
The activity Sucheta Mudgerikar was appointed as a Director was appointed as a Director on 25 Jul 2024 & has been associated with this company since 1 year 5 months . was completed.
Progress on A charge with Others of Rs. 20.00 Cr registered on 17 Jun 2022 with Charge ID 100589116 was modified on 08 Jul 2024. was documented.
The activity Mohamed Aslam Abdul Rahman Sheikh was appointed as a Director was appointed as a Director on 28 Jun 2024 & has been associated with this company since 1 year 6 months . was completed.
CDSCO plans to rope in state drug control organizations to look into the issues raised by Vietnam over the quality of drugs from India.
The CIN of Medley Pharmaceuticals Limited is U24230MH1975PLC018296.
Medley Pharmaceuticals Limited is headquartered at Medley Housed 2 M I D C Area Andheri (East), Mumbai, Maharashtra, 400093.
Medley Pharmaceuticals Limited was incorporated on 15 April 1975.
The current directors of Medley Pharmaceuticals Limited are
The primary industry of Medley Pharmaceuticals Limited is Manufacturing.
Medley Pharmaceuticals Limited is unlisted.
The authorized capital of Medley Pharmaceuticals Limited is ₹33.00 Cr, and the paid-up capital is ₹30.06 Cr.
The compliance status of Medley Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX